IndraLab

Statements


USP3 inhibits DNM1L. 1 / 1
| 1

reach
"We discovered that USP3 overexpression was associated with a significantly extended DNM1L half-life after treatment with CHX, and USP3 downregulation accelerated the protein degradation of DNM1L (Fig. 5d)."